Results 141 to 150 of about 42,587 (212)

A Transcriptional Variant of Anaplastic Lymphoma Kinase Promotes Apoptosis in Ovarian High-Grade Serous Carcinoma. [PDF]

Mol Carcinog
Yokoi A, Yoshimori D, Oguri Y, Hashimura M, Saegusa M.   +4 more
europepmc   +1 more source

Radiotherapy for large ruptured hemorrhagic axillary lymph node metastasis from anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report and review of literature. [PDF]

World J Clin Oncol
Li ZM, Wang YC, Wang KY, Xie NJ, Zhou J, Chang XN, Chen Q, Wang G, Zhang S, Zhou R.   +9 more
europepmc   +1 more source

Leukemic manifestation of anaplastic lymphoma kinase-negative-type anaplastic large-cell lymphoma [PDF]

The Korean Journal of Hematology, 2012
Kim, Jae Wook, Shin, Su-Jin, Park, Chan-Jeoung   +2 more
openaire   +2 more sources

A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis. [PDF]

Surg Case Rep
Takahata Y, Hazama S, Fujii T, Kitahara M, Hino K, Okita K, Nagano H, Tsunedomi R, Hashiyada H, Nakamoto K.   +9 more
europepmc   +1 more source

Identification of APBB1 as a substrate for anaplastic lymphoma kinase. [PDF]

J Biochem
Suzuki Y, Tsubota S, Kadomatsu K, Sakamoto K.   +3 more
europepmc   +1 more source

Anaplastic Lymphoma Kinase-Rearranged Chest Wall-Undifferentiated Small Round Cell Sarcoma With Massive Pleural Effusion and Rapid Progression: A Case With Autopsy Report. [PDF]

Thorac Cancer
Amioka T, Okayasu K, Iwanaga S, Yamamoto M, Tosaka M, Ishikawa T, Kawasaki T, Shimoyama T, Kumagai J.   +8 more
europepmc   +1 more source

Real-world costs, treatment patterns, and clinical outcomes associated with treatments for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer. [PDF]

J Manag Care Spec Pharm
Mudumba R, Liu X, Davis I, Romley JA, Nieva JJ.   +4 more
europepmc   +1 more source

Long-term efficacy and improved overall survival of lorlatinib in anaplastic lymphoma kinase-rearranged lung cancer: is cure a dream or a reality? [PDF]

Transl Lung Cancer Res
Horio Y, Kuroda H, Sasaki E, Masago K.
europepmc   +1 more source

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed [PDF]

, 2016

core   +1 more source

Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison. [PDF]

J Comp Eff Res
Bauer T, Abrahami D, Polli A, Chu H, Ramachandran P, Chandler C, Tan M, Truscott J, Mazieres J, Garcia CA.   +9 more
europepmc   +1 more source